FLT3 and acute myeloid leukemia: In particular, FLT3-mutated AML cells exhibit unique metabolic flexibility by rapidly activating OXPHOS upon oxygen availability, which is crucial for their survival in a fluctuating hypoxic and normoxic environment within the bone marrow [53,54,55].